Agtc News Today

U.S. ag exporters are suffering painful losses after a union stopped work at the ports of Los Angeles and Long Beach amid protracted contract negotiations, according to the Agriculture Transportation Coalition. 

Assenagon Asset Management S.A. lowered its stake in shares of Applied Genetic Technologies Co. (NASDAQ:AGTC – Get Rating) by 35.5% in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 277,656 shares of the biotechnology company’s stock after selling 152,899 shares during the period. Assenagon […]

Shares of Applied Genetic Technologies Co. (NASDAQ:AGTC – Get Rating) have received an average recommendation of “Buy” from the nine analysts that are covering the firm, Marketbeat Ratings reports. One analyst has rated the stock with a sell rating and eight have issued a buy rating on the company. The average 12-month price target among […]

Applied Genetic Technologies (NASDAQ:AGTC – Get Rating) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research note issued to investors on Tuesday, Zacks.com reports. The brokerage currently has a $1.00 price objective on the biotechnology company’s stock. Zacks Investment Research‘s price objective points to a potential upside […]

Applied Genetic Technologies (NASDAQ:AGTC – Get Rating) and TRACON Pharmaceuticals (NASDAQ:TCON – Get Rating) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, profitability, earnings, dividends, risk and institutional ownership. Earnings and Valuation This table compares Applied Genetic […]

Applied Genetic Technologies (NASDAQ:AGTC – Get Rating) and TRACON Pharmaceuticals (NASDAQ:TCON – Get Rating) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, profitability, risk, valuation, earnings, institutional ownership and dividends. Risk and Volatility Applied Genetic Technologies has a […]

StockNews.com started coverage on shares of Applied Genetic Technologies (NASDAQ:AGTC – Get Rating) in a research report issued to clients and investors on Thursday. The firm set a “sell” rating on the biotechnology company’s stock. Other equities analysts have also recently issued reports about the company. Roth Capital reissued a “buy” rating on shares of […]

Applied Genetic Technologies Co. (NASDAQ:AGTC – Get Rating) saw a large decrease in short interest in the month of February. As of February 28th, there was short interest totalling 1,590,000 shares, a decrease of 18.5% from the February 13th total of 1,950,000 shares. Approximately 4.2% of the company’s stock are short sold. Based on an […]

(3) LONDON (dpa-AFX) - Todays Daily Dose brings you news about Applied Genetics Achromatopsia trial results; the deadlock in AstraZeneca vaccine supply in EU; partnership of Lilly, Vir Biotech and GlaxoSmithKline in fighting COVID-19; and ZymeWorks progress with ZW49 study. Read on. 1. Applied Genetic Throws Light on Achromatopsia Trials Applied Genetic Technologies Corp.s (AGTC) phase I/II clinical trials evaluating AAV gene therapy product candidates in patients with achromatopsia caused by ...